EUVIMEDEUVIMED entdecken
Crossref

Beyond Nodal Diagnosis: Preoperative Axillary Core Needle Biopsy for Predicting Axillary Tumor Burden in the Era of Axillary De‐Escalation

Rikiya Nakamura iD, Shouko Hayama, Hideyuki Yamada, Michiko Yamazaki, Reina Okuya, Akinobu Araki

Journal of Surgical Oncology · 29.10.2026

DOI: 10.1002/jso.70437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 29.10.2026. Verfasst von Rikiya Nakamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives With ongoing axillary treatment de‐escalation in breast cancer, preoperative assessment of axillary tumor burden has become increasingly important. We investigated whether pathological information from preoperative axillary lymph node (LN) core needle biopsy (CNB) could stratify final axillary tumor burden.

Methods

We included 473 patients who underwent ultrasound‐guided CNB of suspicious axillary LNs. Associations of metastatic focus size and extranodal extension (ENE) on CNB with final axillary tumor burden were evaluated.

Results

Of 473 patients, 212 had positive and 261 had negative CNB findings. Among 135 CNB‐positive patients undergoing upfront surgery, CNB metastatic focus size correlated with the maximum metastatic focus size in resected LNs (ρ = 0.72, p < 0.001) and the number of positive LNs (ρ = 0.269, p = 0.0016). All 21 patients with a CNB metastatic focus ≤ 2 mm had two or fewer positive LNs. ENE independently predicted pN2–3 disease (OR, 3.61; 95% CI, 1.51–8.68; p = 0.004). Among patients receiving primary systemic therapy, CNB metastatic focus size did not independently predict total pathological complete response. None of 244 CNB‐negative patients undergoing upfront surgery had pN2 or higher disease.

Conclusions

Pathological information from preoperative axillary LN CNB may help stratify axillary tumor burden and support individualized axillary risk assessment in the era of treatment de‐escalation.

Schlagwörter

Stichwörter der Autor:innen

axillary lymph nodeaxillary tumor burdenbreast cancercore needle biopsyextranodal extension

Autor:innen und Institutionen

  • Division of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
  • Division of Diagnostic Pathology, Chiba Cancer Center, Chiba, Japan.

ORCID-Profile: Rikiya Nakamura

Zitieren

APA

Nakamura, R., Hayama, S., Yamada, H., Yamazaki, M., Okuya, R., & Araki, A. (2026). Beyond Nodal Diagnosis: Preoperative Axillary Core Needle Biopsy for Predicting Axillary Tumor Burden in the Era of Axillary De‐Escalation. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70437

Vancouver

Nakamura R, Hayama S, Yamada H, Yamazaki M, Okuya R, Araki A. Beyond Nodal Diagnosis: Preoperative Axillary Core Needle Biopsy for Predicting Axillary Tumor Burden in the Era of Axillary De‐Escalation. Journal of Surgical Oncology. 2026. doi:10.1002/jso.70437

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Rikiya and Hayama, Shouko and Yamada, Hideyuki and Yamazaki, Michiko and Okuya, Reina and Araki, Akinobu},
  title = {Beyond Nodal Diagnosis: Preoperative Axillary Core Needle Biopsy for Predicting Axillary Tumor Burden in the Era of Axillary De‐Escalation},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  doi = {10.1002/jso.70437}
}
Kostenlos starten →